Stock listing

Innate Pharma Sa Class A

Selected listing: IPH · EURONEXT · EUR · FR

Innate Pharma Sa Class A (Euronext:IPH), Health Technology. Latest release Sep 17, 2026: Innate Pharma Reports First Half 2026 Business Update and Financial…

IPH:EURONEXTEURFRUpdated October 3, 2026

Ticker: Euronext:IPH
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Euronext
Currency: EUR

About Innate Pharma Sa Class A

Innate Pharma Sa Class A, traded under the ticker IPH, is a public company based in France. Innate Pharma focuses on developing innovative immunotherapies for cancer treatment.

Latest news from Innate Pharma Sa Class A

Innate Pharma Reports First Half 2026 Business Update and Financial Results

September 17, 2026

Innate and Sobi Announce Partnership Is Now Effective Following Completion of Closing Conditions

September 16, 2026

Innate Pharma to Host Conference Call and Webcast on September 17 for First Half 2026 Financial Results and Business Update

September 10, 2026

Innate Pharma to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

September 2, 2026

Innate Pharma : Announces Pricing of €30 million Offering of Ordinary Shares

August 14, 2026

All Innate Pharma Sa Class A news →

Events

Replays

Innate Pharma S.A. (IPHA) Q1 2026 Earnings Call
Wed, May 13, 2026 · 07:30 AM ET
Watch
Innate Pharma S.A. (IPHA) Q4 2025 Earnings Call
Thu, Mar 26, 2026 · 09:00 AM ET
Watch
Innate Pharma S.A. (IPHA) Q3 2025 Earnings Call
Thu, Nov 13, 2025 · 08:00 AM ET
Watch

Research Innate Pharma Sa Class A

Innate Pharma Sa Class A company profile

View the public company page for Innate Pharma Sa Class A on 6ix.

Innate Pharma Sa Class A news

Read company news and market updates connected to Innate Pharma Sa Class A.

Innate Pharma Sa Class A investor events

Find investor webinars, events, and replay context for Innate Pharma Sa Class A.